ENTRADA THERAPEUTICS
19.04
25-11月-24 16:45:01
15 分の遅延
株式
+0.24
+1.28%
本日の幅
18.94 - 19.71
ISIN
N/A
ソース
NASDAQ
-
Entrada Therapeutics Reports Third Quarter 2024 Financial Results
05 11 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
09 10 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics Promotes Natarajan Sethuraman, PhD, to President of Research and Development
24 9 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
06 9 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports Second Quarter 2024 Financial Results
13 8 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics Announces $100 Million Registered Direct Offering
24 6 2024 07:15:28 提供 Nasdaq GlobeNewswire
-
24 6 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference
03 6 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
16 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports First Quarter 2024 Financial Results
07 5 2024 07:00:01 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
13 3 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at Upcoming Investor Conferences
07 2 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics Promotes Nathan J. Dowden to President
03 1 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics Announces Updates on ENTR-601-44 in Duchenne Muscular Dystrophy
22 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports Third Quarter 2023 Financial Results
07 11 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at Upcoming Investor Conferences
12 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
21 9 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
07 9 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at Upcoming Investor Conferences
29 8 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics Appoints Gina Chapman to its Board of Directors
10 8 2023 07:00:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >